Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

OBJECTIVE: This trial compared the efficacy and safety of transarterial chemoembolisation (TACE) plus sorafenib with TACE alone using a newly established TACE-specific endpoint and pre-treatment of sorafenib before initial TACE. DESIGN: Patients with unresectable hepatocellular carcinoma (HCC) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke, Tsumura, Hidetaka, Kuzuya, Teiji, Isoda, Norio, Yasui, Kohichiroh, Aino, Hajime, Ido, Akio, Kawabe, Naoto, Nakao, Kazuhiko, Wada, Yoshiyuki, Yokosuka, Osamu, Yoshimura, Kenichi, Okusaka, Takuji, Furuse, Junji, Kokudo, Norihiro, Okita, Kiwamu, Johnson, Philip James, Arai, Yasuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398460/
https://www.ncbi.nlm.nih.gov/pubmed/31801872
http://dx.doi.org/10.1136/gutjnl-2019-318934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398460/
https://www.ncbi.nlm.nih.gov/pubmed/31801872
http://dx.doi.org/10.1136/gutjnl-2019-318934

Ejemplares similares